CVEvulnerability

CVE-2026-32921

5.3 MEDIUM Published 2026-03-31 Modified 2026-07-25 Official page ↗
Status
Analyzed
Published
2026-03-31
Last modified
2026-07-25
Assigner
[email protected]
CVSS 4.0 ([email protected])
5.3 MEDIUM — CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
6.3 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS 3.1 ([email protected])
5.0 MEDIUM — CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
Weaknesses
CWE-367

Description

OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.

Affected configurations

• openclaw openclaw (< 2026.3.8)

Related

Weakness · CWE (1)

  • CWE-367 Time-of-check Time-of-use (TOCTOU) Race Condition weakness

References